Immunotherapy, gene editing advances extend to Type 1 Diabetes – EurekAlert (press release)
EurekAlert (press release) |
Immunotherapy, gene editing advances extend to Type 1 Diabetes
EurekAlert (press release) Advances in engineering T cells to treat cancer are paving the way for new immunotherapies targeted at autoimmune diseases, including type 1 diabetes. Now, researchers are also investigating therapies that reprogram T cells to "turn down" an immune … |
